Neogen (NEOG) Income from Continuing Operations (2010 - 2026)
Neogen (NEOG) recorded quarterly Income from Continuing Operations of 17000000.0 in Q1 2026, down 6.76% quarter-over-quarter from 15924000.0 in Q4 2025, and down 55.96% on a YoY basis from 38604166.67 in Q1 2025.
Neogen (NEOG) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Neogen's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 17000000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 55.96% year-over-year to 17000000.0; the TTM figure through Feb 2026 stood at 608830000.0 (down 25.48% YoY), while the FY2025 annual figure was 1092044000.0, down 11491.59% from the prior year.
- Income from Continuing Operations was 17000000.0 for Q1 2026 at Neogen, down from 15924000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 36338000.0 in Q3 2025 to a low of 612244000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 64735882.35 across 5 years, with a median of 3487000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations tumbled 12985.23% in 2024, then jumped 388.19% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 41841000.0 in 2022, then surged by 91.67% to 3487000.0 in 2023, then sank by 12985.23% to 456282000.0 in 2024, then soared by 96.51% to 15924000.0 in 2025, then fell by 6.76% to 17000000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 17000000.0 (Q1 2026), 15924000.0 (Q4 2025), and 36338000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | -17.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -17.00 Mn |
| Nov 30, 2025 | -15.92 Mn |
| Aug 31, 2025 | 36.34 Mn |
| May 31, 2025 | -612.24 Mn |
| Feb 28, 2025 | -10.90 Mn |
| Nov 30, 2024 | -456.28 Mn |
| Aug 31, 2024 | -12.61 Mn |
| May 31, 2024 | -5.42 Mn |
| Feb 29, 2024 | -2.02 Mn |
| Nov 30, 2023 | -3.49 Mn |
| Aug 31, 2023 | 1.50 Mn |
| May 31, 2023 | 5.57 Mn |
| Feb 28, 2023 | 8.19 Mn |
| Nov 30, 2022 | -41.84 Mn |
| Aug 31, 2022 | 5.21 Mn |
| May 31, 2022 | 14.96 Mn |
| Feb 28, 2022 | 5.44 Mn |
| Nov 30, 2021 | 10.83 Mn |
| Aug 31, 2021 | 17.08 Mn |
| May 31, 2021 | 15.76 Mn |